The Global Fund is working with partners and manufacturers of rapid diagnostic tests for HIV and malaria to establish market demand and support procurement of these diagnostics products and related laboratory items for implementing partners.
HIV Global Diagnostic Working Group
The HIV Global Diagnostic Working Group provides a forum to share information and align actions and communications related to improving access to quality-assured, HIV-related in vitro diagnostics for patients.
The Global Fund and the United States Agency for International Development host the working group. Members of the working group include stakeholders of various interests and mandates and include:
African Society for Laboratory Medicine
Centers for Disease Control and Prevention
Clinton Health Access Initiative
The Global Fund
Médecins Sans Frontières
United Nations Children's Fund
Unitaid
United States Agency for International Development
President's Emergency Plan for AIDS Relief
World Health Organization: Prequalification of In Vitro Diagnostics Program and HIV Department
The Global Fund is committed to increasing access to quality-assured rapid diagnostic tests. New suppliers interested in working with the Global Fund and other public sector buyers who would like access to our negotiated terms and pricing should contact Azizkhon Jafarov at .
Documents related to our strategy are available for download here.
The Global Fund uses cookies for anonymized statistics on website use and content performance to help us improve and adapt the website.
To consent to the use of cookies, please click “Accept”. To learn more about your rights and options, please read our Privacy Statement.